Market Cap

Lantheus Holdings, Inc. Market Capitalization:

$4.57 Billion

USD as of Jan. 1, 2026

business Lantheus Holdings, Inc. Company Profile

Lantheus Holdings, Inc. Main Stock Listing

NASDAQ: LNTH

Market Capitalization History of Lantheus Holdings, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Diagnostics & Research
Company Market Cap (USD)
Thermo Fisher Scientific $222.61 B
Danaher $164.98 B
Siemens Healthineers AG $57.84 B
IDEXX Laboratories, Inc. $53.62 B
Lonza Group Ltd $47.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Lantheus Holdings, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $4.57 B -32.64%
Jan. 1, 2025 $6.79 B 54.06%
Jan. 1, 2024 $4.41 B 30.76%
Jan. 1, 2023 $3.37 B 90.79%
Jan. 1, 2022 $1.77 B 56.18%
Jan. 1, 2021 $1.13 B -7.08%
Jan. 1, 2020 $1.22 B 4.10%
Jan. 1, 2019 $1.17 B -26.87%
Jan. 1, 2018 $1.60 B 170.59%
Jan. 1, 2017 $590.7 M 291.71%
Jan. 1, 2016 $150.8 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Lantheus Holdings, Inc. Categories

United States languages Healthcare languages Diagnostics & Research
United States Healthcare United States Diagnostics & Research

Stocks & Indices

Lantheus Holdings, Inc. has the following listings and related stock indices.


Stock: NASDAQ: LNTH

Stock: FSX: 0L8

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.